Data suggests cases of both types of infection are increasing in the country. Learn why and how to defend against potentially ...

Still, infectious disease experts and epidemiologists say it is important to maintain perspective given that less than 10 ...

Topline results expected within a month and may complement positive results of a study of crofelemer for treatment of ...

A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.

Cases of the virus are abnormally high this year, according to health experts, and are especially dangerous for children.

Health experts in the Mid-South are warning about a growing threat from a drug-resistant strain of Shigella, a highly ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

Colorectal cancer is projected to impact more than 158,000 Americans in 2026. Learn about an immunotherapy-based treatment ...

The FDA has accepted a new drug application (NDA) for zipalertinib for the treatment of patients with locally advanced or ...

Here's a look at how to prevent drug-resistant shigella, a type of bacteria that causes shigellosis, a diarrheal infection.

FDA NDA acceptance positions zipalertinib for post-systemic-therapy EGFR ex20ins NSCLC, with a February 27, 2027 PDUFA target ...

XDR Shigella made up 0% of cases a decade ago. It now accounts for 8.5%. More than a third of patients diagnosed with the ...